Acadia Pharmaceuticals (ACAD) PT Lowered to $44 at Needham & Company

March 9, 2021 6:21 AM EST Send to a Friend

Needham & Company analyst Alan ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Acadia Pharmaceuticals (ACAD) PT Lowered to $44 at Needham & Company

Member Login

Free News Feed